Skip to main content
Premium Trial:

Request an Annual Quote

Illumina: Joydeep Goswami

Illumina has appointed Joydeep Goswami as senior VP of corporate development and strategic planning. Reporting to CEO Francis de Souza, he will be responsible for planning, strategic partnerships and acquisitions.

Goswami brings more than 20 years' experience in new product development, partnerships, licensing, and mergers and acquisitions. He comes to Illumina from Thermo Fisher Scientific, where he was president of the clinical next-generation sequencing and oncology business unit. He has also held leadership positions at Life Technologies and Invitrogen. He holds a doctorate in chemical engineering and an MBA from the Massachusetts Institute of Technology.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.